However, when tested under the above mentioned circumstances, the dogs may have detected and responded to odors differing from that of normal skin or odors directly or indirectly associated with cancer, such as inflammation, necrosis, or metabolic products that often exist in patients, especially those with advanced disease, rather than specifically to cancer itself.
Thus, it is important to ascertain whether or not human cancers are characterized by specific odors. We hypothesized that if ovarian carcinoma has some specific odor, dogs may be trained to detect it.
The aim of this study was to investigate the possibilities to train dogs to differentiate human ovarian cancer from healthy samples and, hopefully, from other gynecological carcinomas.
Introduction
Many cancers are detected in late stages with consequential high mortality rates. It is thus essential to develop inexpensive and simple methods for early diagnosis. In 1989, Williams and co-workers presented the first hypothesis that dogs may be able to detect malignant tumors by scent. 1 Since then, there have been several anecdotal claims of scent detection of skin cancer. 2 Detection of other malignancies, such as melanoma 3 and bladder, 4 breast, and lung cancer, has also been reported in peer-reviewed scientific journals. 5 Pickel et al trained 2 dogs to detect melanomas. Willis et al have reported that dogs selected urine from bladder cancer patients with a mean success rate of 41%. McCulloch et al trained dogs to differentiate between exhalations of patients with lung and breast cancers and those of healthy individuals. Among the lung cancer patients and controls, the sensitivity was 0.99, and the overall specificity was 0.99. With regard to the breast cancer patients, the corresponding figures were 0.88 and 0.98, respectively.
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The high mortality rate associated with ovarian carcinoma is mainly owing to late diagnosis. It is thus essential to develop inexpensive and simple methods for early diagnosis. Papers on canine scent detection of malignancies such as melanoma and bladder, lung, and breast cancer have recently been published in peer-reviewed journals, indicating a new diagnostic tool for malignancies. However, in these studies the dogs may have responded to odors associated with cancer, such as inflammation or metabolic products, rather than specifically to cancer itself. Therefore, it is important to ascertain whether or not human cancers are characterized by specific odors. We hypothesized that if ovarian carcinoma emits a specific odor, dogs may be trained to detect it.
Using our training method, we taught a dog to distinguish different histopathological types and grades of ovarian carcinomas, including borderline tumors, from healthy control samples. Double-blind tests showed 100% sensitivity and 97.5% specificity. Moreover, the odor of ovarian carcinomas seems to differ from those of other gynecological malignances such cervical, endometrial, and vulvar carcinomas. Our study strongly suggests that the most common ovarian carcinomas are characterized by a single specific odor.
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Tumors were thawed to room temperature for 15-30 minutes before being used in the training. The tumors and the similar-sized normal control samples were kept and treated in separate rooms under almost sterile conditions to eliminate the possible mixing of different odor compounds. Other gynecological tumor samples, such as cervical, vulvar, and endometrial carcinomas, were also taken from this tumor bank and treated identically to the ovarian carcinomas ( Table 2) .
Controls
Abdominal fat and muscle, and small bowel samples were used as controls. Tumor and control samples (fat from abdominal wall) belonging to the same individuals were used in several exercises during the training period (only < 0.1% of all controls used).
In addition, sample imprints for cytological examination were performed on all tumors and all controls. The imprints were examined to verify the presence of malignancy (established when at least 50% of cells were malignant). Controls were accepted only in the complete absence of malignant cells.
Dog
A 4-year-old black Riesenschnauzer (chip no. 96700000038 9928) was trained twice a week for 12 months.
Tests
Single-blind tests. The handler was blinded to the location of target and nontarget samples.
Double-blind tests.
A judge from the Swedish Working Dog Club participated in these test series. Both the judge and the handler were blinded to the location of the target samples. The double-blind tests were documented both on paper and DVD.
Dog's responses. Positive responses were (1) indicating the target box by scratching with foreleg(s) and (2) sniffing at, but not indicating, control samples. Negative responses were (1) not indicating target and (2) indicating the control box.
Training
Learning odor signature. Training was initially designed as a selection model, resembling that of sniffer dogs. In summary, the dog was requested to sniff a few rags attached to pieces of string and placed on the floor. One of them contained an ovarian cancer sample. When the dog showed interest in the target, the handler quickly snatched it away. This was repeated several times. This method reinforces the dog's natural hunting behavior and strengthens her motivation to select the target. 47  seropapillary  IVB  3  67  seropapillary  IIIC  3  69  seropapillary  IC  1  84  clear cell  IIB  3  91  seropapillary  IIIC  3  98  seropapillary  IA  1  99  mucinous/borderline  IA  111  serous/borderline  IA  113  mucinous  IIIB  2  118  seropapillary  IIIA  3  126  seropapillary  IA  2  140  seropapillary  IIA  1  147  mucinous  IC  1  154  seropapillary  IIIB  2  173  seropapillary  IIIC  3  175  undifferentiated  IIIA  176  carcinosarcoma  IIA  196  seropapillary  IIIB  3  198  seropapillary  IV  3  224  mucinous  IIIC  3  233  endometroid  IIB  3  252  endometroid  IIIC  1  255  endometroid  IIIC  3  305  seropapillary  IIIC  2  340  seropapillary  IB  3  348  undifferentiated  IA  357  seropapillary  IIIC  3  435  seropapillary  IIIC  3  441  seropapillary  IIIB  1  1*  seropapillary  IIIC  3  2*  seropapillary  IIB  3 NOTE: Bold type: tumors also used in single-blind experiments. Two tumors which had control material belonging the same patient. II  42  squamous  II  3  420  squamous  I  2  413  squamous  II  2  Uterine corpus cancer  32  adenocarcinoma  II  3  143  adenocarcinoma  IB  1  200  adenocarcinoma  II  1  74  adenocarcinoma  II  2  73  adenocarcinoma  IA  2  58  adenocarcinoma  IB  3  Cervical cancer  199  squamous  IIB  3  734  squamous  IIB  3  2009  squamous  IIB  2 During the initial training period, only high-grade and advanced-stage (III or IV) seropapillary carcinomas were used. After the dog successfully identified them, we began to use mucinous and endometroid carcinomas and carcinosarcomas. The grade and stage of tumors were also changed to less advanced forms of disease. In this phase of the training, in addition to the method described above, another method for training police dogs in person identification was also occasionally used. In summary, a tumor sample was placed with cotton wool pads in a closed glass jar for 24 to 168 hours at room temperature, and these pads were subsequently used as targets. The pads did not directly affect the tumor sample. Tumor samples went dry at least on day 1 or 2, depending on the number of cotton wool pads used, without either macroscopic or microscopic signs of rot processes. The dog had no observed difficulties finding these pads, irrespective of odor concentrations. After about 6 months of training, the dog detected earlystage and low-grade tumors with a fair degree of certainty.
Learning odor discrimination. When the dog was sure to identify even low concentrations of the target vapor (she found the hidden tumor), we began using nontarget odor as controls. Wooden boxes (25 x 25 x 25 cm) containing glass containers were used. Target and nontarget samples were placed in the glass containers, which were covered with perforated lids. Both the boxes and the containers were cleaned with hot water after each exercise. We initially used only 1 control specimen, and the dog was permitted to choose the right parcel and disregard the control.
Step by step, we increased the number of control samples to 4 (the combination of 4 controls and 1 target is called a section). Later, we used series consisting of 2 target and 8 control samples (ie, 2 sections). To minimize external influence, the exercises were carried out in several training rooms in random sequence.
Learning to distinguish extraneous odors. Although target and control samples were handled carefully in this phase of the training, other components such as boxes and glass containers were contaminated by different individuals, including the handler. However, this contamination had no observable influence on the dog's target identification during this last period of training.
No gynecological carcinomas other than ovarian cancer were tested during the training phases.
Statistical Methods
Sensitivity and specificity are calculated as in the context of diagnostic testing. That is, the sensitivity (or the true positive rate) of the test is the proportion of cancer samples that are correctly identified by the dog. The specificity (or the true negative rate) is the proportion of control samples negatively indicated by the dog.
Binomial probability distribution is used to compare the performance of the dog with random selection of sample boxes. Each test consists of a number of runs (series), where each run includes 2 target samples and 8 controls. Under the assumption of random positive indication by the dog, the number of correctly identified runs is a binomial distribution with success probability 2/10. Sensitivity is therefore a/(a+c), and specificity is d/(b+d) ( Table 3 ).
Results

Single-blind Tests
As the training period came to an end, we designed 2 separate single-blind tests, primarily to evaluate the training results, but also to elucidate the issues in focus.
Discriminate between ovarian carcinomas and healthy tissues.
Tumor samples previously used in the training phases were used. Four samples from each of 5 different patients' tumors (tumor no. 305, 340, 357, 435, 441) were used in 10 series, 2 series per test day. The remaining 80 boxes were loaded with randomly selected fat and intra-abdominal muscle (myoma) samples from several different patients. Moreover, 2 pieces of healthy postmenopausal ovary from 2 individuals were also used as controls.
The dog correctly identified all cancer samples and did not make any positive indication of controls, which means both sensitivity and specificity was 100%. The probability that the dog correctly identifies the 2 target samples in all 10 series just by chance is 1.02 × 10 -7 (Table 4 ). carcinoma samples from the same 5 tumors were used in 4 separate series. All 8 ovarian carcinomas were correctly indicated. Two endometrial adenocarcinomas and 1 squamous cervical carcinoma were also indicated as targets. This test resulted in a sensitivity of 100% (8/8) and specificity of 91% (29/32). The probability that the dog correctly identifies the 2 target samples in 8 series just by chance is 2.56 x 10 -6 ( Table 5) .
Discriminate between ovarian carcinomas and other gynecological carcinomas. Eight randomly selected ovarian
Double-blind Tests
Discriminate between ovarian carcinomas and healthy tissues. Ovarian carcinoma samples from 20 different individuals were used as targets. These tumors had not been used previously in the training or in the single-blind tests ( Table 6 ). Samples of small bowel, muscle, fat, and 2 pieces of healthy postmenopausal ovary were set out as controls. In 10 series, including 100 examined boxes, the dog identified all 20 ovarian carcinomas without difficulty. However, she did indicate 1 fat and 1 muscle sample as targets in the same series. The dog correctly identified all cancer samples (sensitivity = 100%). The 2 positive indications of control samples resulted in 97.5% specificity (78/80) ( Table 7) .
One single-blind and 1 double-blind test series were not evaluated, because of either external or internal disturbances considerably stressing the dog, making it almost impossible for her to work. These series were, however, recorded on DVD.
Discussion
Using our training method, we taught a dog to discriminate different histopathological types and grades of ovarian carcinomas, including borderline tumors, from healthy control tissue. Sensitivity and specificity rates in the double-blind test series were 100% and 97.5%, respectively.
Thus, this study strongly suggests that the most common ovarian carcinomas may be characterized by a single, specific odor. This odor may be distinguished, by trained dogs, from those of healthy intra-abdominal tissues, including postmenopausal ovary.
A question may be raised whether the dog discriminated between "ovarian" versus "non-ovarian" tissues. However, in 2 tests she marked all 40 ovarian cancer tissues with 100% sensitivity, whereas she did not mark the 4 postmenopausal ovarian tissues that were used as controls. So the dog clearly could discriminate between malignant and benign ovarian tissues. Moreover, the odor of ovarian carcinomas seems to differ from those of other gynecological malignances such as cervical, endometrial, and vulvar carcinomas.
The sensitivity of this method is very high. Although a small number of other gynecological malignancies were tested, our results suggest a relatively high degree of specificity, as well. Recently published studies suggest important possible connections between cancer and some "abnormal" odor. 2, 4, 5 However, in the cases of skin cancer and melanoma, the dog's reaction is probably not specific to malignancy. It is well-known that many dogs lick lesions, including inflammation and sores, on their owners' skin as they do on their own skin. Thus, the dogs' reactions in the above responded to odors associated with cancer, such as inflammation or metabolic products, rather than specifically to cancer, as the authors indeed suggested. 5 Thus, our study presents the first evidence of a specific odor emitted by ovarian carcinomas. When it comes to other gynecological malignancies, which were not indicated by the dog in our study, it may be that all cancers may have their specific odors, characteristic for each malignancy.
Our study further shows that early-stage and lowgrade ovarian carcinomas emit the same specific smell as advanced tumors. This observation suggests that the specific cancer odor may be used for screening, diagnosis, and differential diagnosis of different malignant diseases in the future when it becomes technologically possible.
One important observation during the training period was that use of fat from the same individuals from whom the carcinomas were removed did not increase the number of failures (data not shown). The absence of reaction by the dog suggests that a general body odor, including all organs did not exist.
Although the dog did not indicate healthy postmenopausal ovary samples as targets, we believe that the carcinoma-specific odor is organ dependent, at least to some extent. Our observation that the dog distinguished between healthy ovarian tissues and ovarian carcinomas may be explained by biological changes during carcinogenesis, which probably changed the organ-specific odor to carcinoma-specific. This carcinoma-specific odor, however, does not represent a general carcinoma odor in the human body but instead an organ-related odor. This could, for example, be an explanation for the odor differences in different malignancies.
We do not believe that dogs may be used in clinical practice. Dogs as "living instruments" may be influenced by several factors before and during their work, leading to changes in the accuracy rates. However, under controlled circumstances they may be used in experiments to further explore this very interesting new property of malignancies. Similar suggestions were recently published by Gordon et al. 6 
